Randy H Thurman insider trades
Open-market stock purchases and sales by Randy H Thurman, Director at Outlook Therapeutics, Inc, from SEC Form 4 filings since May 10, 2010.
Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -39%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 26, 2026 | OTLK Outlook Therapeutics, Inc | Bought | $2.1K |
Companies traded
- OTLK Outlook Therapeutics, Inc: 3 buys, last May 26, 2026
- TFFP TFF Pharmaceuticals, Inc: 2 buys, 3 sales, last Sep 29, 2022
- ONS Oncobiologics, Inc: other filings, last Nov 9, 2018
- MDRX Allscripts HealthCare Solutions, Inc: 2 buys, last May 22, 2017
- LENS Presbia plc: 2 buys, last Mar 13, 2017
- ARNI Arno Therapeutics, Inc: 2 buys, last Jan 24, 2014
- OFIX Orthofix International N V: other filings, last Nov 5, 2013
- BEAT CardioNet, Inc: other filings, last May 2, 2011